Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis Source: Eur Respir J 2013; 42: 708-720 Year: 2013
Cost–benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals Source: Eur Respir J 2016; 47: 575-587 Year: 2016
Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012
Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India Source: Eur Respir J 2014; 44: 1090-1093 Year: 2014
Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting Source: Eur Respir J, 51 (3) 1702345; 10.1183/13993003.02345-2017 Year: 2018
Early tuberculosis treatment monitoring by Xpert® MTB/RIF Source: Eur Respir J 2012; 39: 1269-1271 Year: 2012
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Source: Eur Respir J 2016; 48: 516-525 Year: 2016
A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil Source: ERJ Open Res, 5 (3) 00043-2019; 10.1183/23120541.00043-2019 Year: 2019
Use of Xpert MTB/RIF Ultra assays among paediatric tuberculosis experts in Europe Source: Eur Respir J, 51 (5) 1800346; 10.1183/13993003.00346-2018 Year: 2018
Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016
Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF Source: Eur Respir J 2013; 42: 252-271 Year: 2013
Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014
The yield of bronchoscopy in sputum Xpert MTB/Rif negative tuberculosis in the Xpert era. Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020
Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021
A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018 Year: 2019
Xpert MTB/RIF testing of pooled induced sputum Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014